Search through all our worldwide HIV and AIDS news and features, using the topics below to filter your results by subjects including HIV treatment, transmission and prevention, and hepatitis and TB co-infections.

Hepatitis and HIV news

Show

From To
New EASL guidelines prioritise interferon-free hepatitis C treatment

The European Association for the Study of the Liver (EASL) released its latest hepatitis C treatment guidelines at the 50th International Liver Congress which took place last

Published
15 hours ago
By
Liz Highleyman
Alcohol misuse the strongest predictor of severe liver damage and death in French people with hepatitis C

People with hepatitis C have a much greater risk of liver-related hospitalisation or death if they have an alcohol use disorder or another serious comorbidity such as

Published
16 hours ago
By
Keith Alcorn
Gilead uses Georgia as free-drug testbed for hepatitis C elimination

Gilead Sciences is seeking to convince governments and multilateral agencies worldwide that hepatitis C can be eliminated with a demonstration project in Georgia offering free drugs to all those who need them.

Published
16 hours ago
From
Reuters
Expanded vaccination and treatment could help eliminate hepatitis B worldwide

While universal infant hepatitis B virus (HBV) vaccination has already led to major advances in reducing new infections in some settings, further expansion of prevention and treatment

Published
25 April 2015
By
Liz Highleyman
Grazoprevir/elbasvir highly effective in treatment-experienced and HIV-coinfected hepatitis C patients

The combination of grazoprevir and elbasvir without ribavirin is highly effective in curing hepatitis C infection in 12 weeks in some groups of treatment-experienced patients and in

Published
25 April 2015
By
Keith Alcorn
Advanced liver damage is common in people with undiagnosed hepatitis C in US survey

Around one in five people with hepatitis C in the United States who do not know of their infection may already have advanced liver damage and be

Published
25 April 2015
By
Keith Alcorn
Grazoprevir / elbasvir highly effective in previously untreated hepatitis C

A 12-week course of the combination of grazoprevir and elbasvir cured 95% of previously untreated people with genotypes 1, 4 or 6 hepatitis C virus (HCV), according

Published
24 April 2015
By
Keith Alcorn
Sofosbuvir/ledipasvir plus ribavirin shows high cure rate for hepatitis C patients with advanced liver disease

An oral regimen of sofosbuvir/ledipasvir (Harvoni) and ribavirin taken for 12 or 24 weeks produced sustained virological response (SVR) rates of 85-88% for people with genotype

Published
24 April 2015
By
Liz Highleyman
Merck HCV combination achieves 90% cure in advanced cirrhosis

A 12-week course of treatment with two direct-acting antivirals in development by Merck cured hepatitis C infection in 90% of people with very advanced cirrhosis and at

Published
23 April 2015
By
Keith Alcorn
Merck HCV combination effective after failure of first generation of direct-acting antivirals

A 12-week course of treatment with two direct-acting antivirals in development by Merck plus ribavirin cured 95% of people with hepatitis C who had experienced failure of

Published
23 April 2015
By
Keith Alcorn
← First12345...164Next →

Filter by country